Sonja Nelson - 11 Dec 2023 Form 4 Insider Report for Ambrx Biopharma, Inc.

Role
Chief Financial Officer
Signature
/s/ Sonja Nelson
Issuer symbol
N/A
Transactions as of
11 Dec 2023
Net transactions value
$0
Form type
4
Filing time
11 Dec 2023, 17:17:24 UTC
Previous filing
31 Oct 2023
Next filing
13 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMAM Common Stock Award $0 +50,000 +10% $0.000000 545,776 11 Dec 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs") payable in common stock of the Issuer granted to the Reporting Person on December 11, 2023 (the "Grant Date"). The RSUs were granted in connection with the completion of the year-end review process and will be issued pursuant to the Company's Amended and Restated 2021 Equity Incentive Plan.
F2 The RSUs will vest over thirty-six (36) months as follows: (i) one-sixth (1/6) of the RSUs will vest on the six (6)-month anniversary of the Grant Date, and (ii) one-twelfth (1/12) of the RSUs will vest on a quarterly basis thereafter.